132 related articles for article (PubMed ID: 19782417)
1. Recurrence pattern after [(18)F]fluoroethyltyrosine-positron emission tomography-guided radiotherapy for high-grade glioma: a prospective study.
Weber DC; Casanova N; Zilli T; Buchegger F; Rouzaud M; Nouet P; Vees H; Ratib O; Dipasquale G; Miralbell R
Radiother Oncol; 2009 Dec; 93(3):586-92. PubMed ID: 19782417
[TBL] [Abstract][Full Text] [Related]
2. High-grade glioma radiation therapy target volumes and patterns of failure obtained from magnetic resonance imaging and 18F-FDOPA positron emission tomography delineations from multiple observers.
Kosztyla R; Chan EK; Hsu F; Wilson D; Ma R; Cheung A; Zhang S; Moiseenko V; Benard F; Nichol A
Int J Radiat Oncol Biol Phys; 2013 Dec; 87(5):1100-6. PubMed ID: 24161427
[TBL] [Abstract][Full Text] [Related]
3. FET-PET for malignant glioma treatment planning.
Niyazi M; Geisler J; Siefert A; Schwarz SB; Ganswindt U; Garny S; Schnell O; Suchorska B; Kreth FW; Tonn JC; Bartenstein P; la Fougère C; Belka C
Radiother Oncol; 2011 Apr; 99(1):44-8. PubMed ID: 21458093
[TBL] [Abstract][Full Text] [Related]
4. [(18)F]Fluoroethyltyrosine- positron emission tomography-guided radiotherapy for high-grade glioma.
Weber DC; Zilli T; Buchegger F; Casanova N; Haller G; Rouzaud M; Nouet P; Dipasquale G; Ratib O; Zaidi H; Vees H; Miralbell R
Radiat Oncol; 2008 Dec; 3():44. PubMed ID: 19108742
[TBL] [Abstract][Full Text] [Related]
5. Utilizing 18F-fluoroethyltyrosine (FET) positron emission tomography (PET) to define suspected nonenhancing tumor for radiation therapy planning of glioblastoma.
Hayes AR; Jayamanne D; Hsiao E; Schembri GP; Bailey DL; Roach PJ; Khasraw M; Newey A; Wheeler HR; Back M
Pract Radiat Oncol; 2018; 8(4):230-238. PubMed ID: 29730279
[TBL] [Abstract][Full Text] [Related]
6. Analysis of FET-PET imaging for target volume definition in patients with gliomas treated with conformal radiotherapy.
Rieken S; Habermehl D; Giesel FL; Hoffmann C; Burger U; Rief H; Welzel T; Haberkorn U; Debus J; Combs SE
Radiother Oncol; 2013 Dec; 109(3):487-92. PubMed ID: 23953407
[TBL] [Abstract][Full Text] [Related]
7. Pre-irradiation tumour volumes defined by MRI and dual time-point FET-PET for the prediction of glioblastoma multiforme recurrence: A prospective study.
Harat M; Małkowski B; Makarewicz R
Radiother Oncol; 2016 Aug; 120(2):241-7. PubMed ID: 27378734
[TBL] [Abstract][Full Text] [Related]
8. Utilizing 18F-fluoroethyl-l-tyrosine positron emission tomography in high grade glioma for radiation treatment planning in patients with contraindications to MRI.
Jaymanne DT; Kaushal S; Chan D; Schembri G; Brazier D; Bailey D; Wheeler H; Back M
J Med Imaging Radiat Oncol; 2018 Feb; 62(1):122-127. PubMed ID: 28980392
[TBL] [Abstract][Full Text] [Related]
9. Impact of
Debus C; Waltenberger M; Floca R; Afshar-Oromieh A; Bougatf N; Adeberg S; Heiland S; Bendszus M; Wick W; Rieken S; Haberkorn U; Debus J; Knoll M; Abdollahi A
Sci Rep; 2018 May; 8(1):7201. PubMed ID: 29740097
[TBL] [Abstract][Full Text] [Related]
10. Report of first recurrent glioma patients examined with PET-MRI prior to re-irradiation.
Fleischmann DF; Unterrainer M; Corradini S; Rottler M; Förster S; la Fougère C; Siepmann T; Schwaiger M; Bartenstein P; Belka C; Albert NL; Niyazi M
PLoS One; 2019; 14(7):e0216111. PubMed ID: 31339892
[TBL] [Abstract][Full Text] [Related]
11. Margin reduction in radiotherapy for glioblastoma through
Fleischmann DF; Unterrainer M; Schön R; Corradini S; Maihöfer C; Bartenstein P; Belka C; Albert NL; Niyazi M
Radiother Oncol; 2020 Apr; 145():49-55. PubMed ID: 31923709
[TBL] [Abstract][Full Text] [Related]
12. Influence of FDG-PET on computed tomography-based radiotherapy planning for locally recurrent nasopharyngeal carcinoma.
Zheng XK; Chen LH; Wang QS; Wu HB; Wang HM; Chen YQ; Yan WP; Li QS; Xu YK
Int J Radiat Oncol Biol Phys; 2007 Dec; 69(5):1381-8. PubMed ID: 17869450
[TBL] [Abstract][Full Text] [Related]
13. [F-DOPA PET/MR based target definiton in the 3D based radiotherapy treatment of glioblastoma multiforme patients. First Hungarian experiences].
Sipos D; Tóth Z; Lukács G; Bajzik G; Hadjiev J; Cselik Z; Repa I; Kovács Á
Ideggyogy Sz; 2019 May; 72(5-6):209-215. PubMed ID: 31241266
[TBL] [Abstract][Full Text] [Related]
14. 18F-FET PET for planning of thermotherapy using magnetic nanoparticles in recurrent glioblastoma.
Plotkin M; Gneveckow U; Meier-Hauff K; Amthauer H; Feussner A; Denecke T; Gutberlet M; Jordan A; Felix R; Wust P
Int J Hyperthermia; 2006 Jun; 22(4):319-25. PubMed ID: 16754352
[TBL] [Abstract][Full Text] [Related]
15. l-[METHYL-(11)C] methionine positron emission tomography for target delineation in malignant gliomas: impact on results of carbon ion radiotherapy.
Mahasittiwat P; Mizoe JE; Hasegawa A; Ishikawa H; Yoshikawa K; Mizuno H; Yanagi T; Takagi R; Pattaranutaporn P; Tsujii H
Int J Radiat Oncol Biol Phys; 2008 Feb; 70(2):515-22. PubMed ID: 17900820
[TBL] [Abstract][Full Text] [Related]
16. [F-18]-fluorodeoxyglucose positron emission tomography for targeting radiation dose escalation for patients with glioblastoma multiforme: clinical outcomes and patterns of failure.
Douglas JG; Stelzer KJ; Mankoff DA; Tralins KS; Krohn KA; Muzi M; Silbergeld DL; Rostomily RC; Scharnhorst J; Spence AM
Int J Radiat Oncol Biol Phys; 2006 Mar; 64(3):886-91. PubMed ID: 16242251
[TBL] [Abstract][Full Text] [Related]
17. Patterns of failure for patients with glioblastoma following O-(2-[
Lundemann M; Costa JC; Law I; Engelholm SA; Muhic A; Poulsen HS; Munck Af Rosenschold P
Radiother Oncol; 2017 Mar; 122(3):380-386. PubMed ID: 28110959
[TBL] [Abstract][Full Text] [Related]
18. Diffusion-weighted MRI and ADC versus FET-PET and GdT1w-MRI for gross tumor volume (GTV) delineation in re-irradiation of recurrent glioblastoma.
Popp I; Bott S; Mix M; Oehlke O; Schimek-Jasch T; Nieder C; Nestle U; Bock M; Yuh WTC; Meyer PT; Weber WA; Urbach H; Mader I; Grosu AL
Radiother Oncol; 2019 Jan; 130():121-131. PubMed ID: 30219612
[TBL] [Abstract][Full Text] [Related]
19. (18)F-fluoromethylcholine (FCho), (18)F-fluoroethyltyrosine (FET), and (18)F-fluorodeoxyglucose (FDG) for the discrimination between high-grade glioma and radiation necrosis in rats: a PET study.
Bolcaen J; Descamps B; Deblaere K; Boterberg T; De Vos Pharm F; Kalala JP; Van den Broecke C; Decrock E; Leybaert L; Vanhove C; Goethals I
Nucl Med Biol; 2015 Jan; 42(1):38-45. PubMed ID: 25218024
[TBL] [Abstract][Full Text] [Related]
20. Positron emission tomography for radiation treatment planning.
Grosu AL; Piert M; Weber WA; Jeremic B; Picchio M; Schratzenstaller U; Zimmermann FB; Schwaiger M; Molls M
Strahlenther Onkol; 2005 Aug; 181(8):483-99. PubMed ID: 16044216
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]